IHS Chemical Week

People & Business :: Companies

Solvay to Buy Arkema?

7:45 AM MDT | October 26, 2009 | Ian Young and Natasha Alperowicz

Arkema's share price has been rising for the past month on investor speculation that the company may be an acquisition target for Solvay. The speculation follows Solvay's announcement in September that it has agreed to sell its pharmaceuticals business to Abbott Laboratories for €4.5 billion. Solvay says it plans to reinvest proceeds from the divestment in the company's chemicals and plastics businesses, and analysts say Solvay may use the funds to make a major acquisition. Solvay and Arkema would be a good fit because there are important business overlaps...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa